NASDAQ:DUSA - Davis Select U.S. Equity ETF Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $21.6427 -0.10 (-0.44 %) (As of 12/14/2018 01:17 AM ET)Previous Close$21.7384Today's Range$21.57 - $21.8052-Week Range$21.27 - $26.54Volume23,061 shsAverage Volume14,373 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield0.73%BetaN/A ProfileDiscussionChartDividendFinancialsInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email DUSA Pharmaceuticals, Inc. (DUSA) is a vertically integrated dermatology company. The Company is developing and marketing Levulan photodynamic therapy (Levulan PDT). The Company's marketed products include Levulan Kerastick 20% topical solution with PDT and the BLU-U brand light source. Levulan Kerastick and BLU-U are used for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp. During the year ended December 31, 2011, it initiated an exploratory DUSA-sponsored clinical trial designed to study the broad area application and/or short drug incubation (BASDI), method of using the Levulan Kerastick, which is being carried out at 10 clinical trial sites. DUSA manufactures its Levulan Kerastick in its Wilmington, Massachusetts facility. Its wholly owned subsidiaries include DUSA Pharmaceuticals New York, Inc. and Sirius Laboratories, Inc. As of December 31, 2011, DUSA ceased marketing and selling its remaining Non-PDT products, which were ClindaReach and Meted. Receive DUSA News and Ratings via Email Sign-up to receive the latest news and ratings for DUSA and its competitors with MarketBeat's FREE daily newsletter. Basic Details Issuer Davis Advisors Fund NameDavis Select U.S. Equity ETF Tax ClassificationRegulated Investment Company SymbolNASDAQ:DUSA Inception Date1/11/2017 Fund ManagerChristopher Davis, Danton Goei WebN/A PhoneN/A Fund Focus Asset ClassEquity BenchmarkNot Applicable CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$103.26 million Average Daily Volume$32,776.00 Discount/Premium1.01% ETF Expenses Management Fee0.55% Other Expenses0.26% Total Expenses0.81% Fee Waiver-0.16% Net Expenses0.65%Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorDavis Selected Advisers, L.P. CustodianState Street Bank and Trust Company DistributorForeside Fund Services, LLC Transfer AgentState Street Bank and Trust Company Trustee Lead Market MakerVirtu Financial Davis Select U.S. Equity ETF (NASDAQ:DUSA) Frequently Asked Questions What is Davis Select U.S. Equity ETF's stock symbol? Davis Select U.S. Equity ETF trades on the NASDAQ under the ticker symbol "DUSA." How often does Davis Select U.S. Equity ETF pay dividends? What is the dividend yield for Davis Select U.S. Equity ETF? Davis Select U.S. Equity ETF announced a special dividend on Tuesday, December 26th. Shareholders of record on Wednesday, December 27th will be paid a dividend of $0.0752 per share on Thursday, December 28th. The ex-dividend date of this dividend is Tuesday, December 26th. View Davis Select U.S. Equity ETF's Dividend History. Has Davis Select U.S. Equity ETF been receiving favorable news coverage? News articles about DUSA stock have trended somewhat positive on Friday, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Davis Select U.S. Equity ETF earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave news headlines about the healthcare company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. Who are Davis Select U.S. Equity ETF's major shareholders? Davis Select U.S. Equity ETF's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Morgan Stanley (7.06%), LPL Financial LLC (1.48%), D.A. Davidson & CO. (0.86%), IFP Advisors Inc (0.86%), Jane Street Group LLC (0.39%) and Private Advisor Group LLC (0.39%). Which major investors are buying Davis Select U.S. Equity ETF stock? DUSA stock was purchased by a variety of institutional investors in the last quarter, including Morgan Stanley, IFP Advisors Inc, Jane Street Group LLC, Private Advisor Group LLC, LPL Financial LLC and D.A. Davidson & CO.. How do I buy shares of Davis Select U.S. Equity ETF? Shares of DUSA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Davis Select U.S. Equity ETF's stock price today? One share of DUSA stock can currently be purchased for approximately $21.6427. MarketBeat Community Rating for Davis Select U.S. Equity ETF (NASDAQ DUSA)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 61 (Vote Outperform)Underperform Votes: 70 (Vote Underperform)Total Votes: 131MarketBeat's community ratings are surveys of what our community members think about Davis Select U.S. Equity ETF and other stocks. Vote "Outperform" if you believe DUSA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DUSA will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/14/2018 by MarketBeat.com StaffFeatured Article: What are the Different Types of Leveraged Buyouts?